Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Tiziana Life Sciences
TLSA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.940000
0.02
2.14%
Pre-Market: 7:25 PM EDT
15 minutes delayed
Get Report
Comment
Tiziana Life Sciences (TLSA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Tiziana Life Sciences (NASDAQ:TLSA) Stock
Tiziana Life Sciences Stock (NASDAQ: TLSA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 19, 2024
Tiziana Life Sciences Announced The National ...
Benzinga Newsdesk
Monday, August 19, 2024
Tiziana Life Sciences Appoints Ivor Elrifi As...
Benzinga Newsdesk
Wednesday, August 14, 2024
Tiziana Life Sciences Announced That It Has R...
Benzinga Newsdesk
Wednesday, July 24, 2024
Tiziana Life Sciences shares are trading high...
Benzinga Newsdesk
Tiziana Life Sciences Granted FDA Fast Track ...
Benzinga Newsdesk
Wednesday, July 03, 2024
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Friday, June 28, 2024
Tiziana shares are trading higher after the c...
Bill Haddad
Tiziana Life Sciences Receives $3.4M Non-Dilu...
Benzinga Newsdesk
Wednesday, June 26, 2024
Tiziana Life Sciences Says It Will Dose First...
Benzinga Newsdesk
Monday, June 17, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, June 11, 2024
Tiziana Life Sciences Receives FDA Acceptance...
Benzinga Newsdesk
Friday, June 07, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, June 06, 2024
Tiziana Life Sciences Reports Six-Month Quali...
Benzinga Newsdesk
Tuesday, June 04, 2024
Tiziana Life Sciences Submits Grant Applicati...
Benzinga Newsdesk
Monday, May 13, 2024
Tiziana Life Sciences Submits FDA Request To ...
Benzinga Newsdesk
Thursday, April 25, 2024
Tiziana Life Sciences Reports 3-Month Neuroim...
Benzinga Newsdesk
Wednesday, April 24, 2024
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, April 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Tiziana Life Sciences shares are trading high...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tiziana Life Sciences Announces FDA Allowance...
Benzinga Newsdesk
Monday, April 22, 2024
Tiziana Life Sciences Announces Additional Cl...
Benzinga Newsdesk
Friday, April 19, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tiziana Life Sciences Says Study Results From...
Benzinga Newsdesk
Thursday, April 18, 2024
Tiziana Life Sciences shares are trading high...
Benzinga Newsdesk
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Tiziana Life Sciences Announces New Quantitat...
Benzinga Newsdesk
Thursday, April 11, 2024
Tiziana Life Sciences Plans Platform Presenta...
Benzinga Newsdesk
Tuesday, March 05, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tiziana Life Sciences To Present Data Of Intr...
Benzinga Newsdesk
Monday, January 08, 2024
Tiziana Life Sciences Announces Updated Clini...
Benzinga Newsdesk
Friday, January 05, 2024
Tiziana Life Sciences Says It Filed New Paten...
Benzinga Newsdesk
Tuesday, December 19, 2023
Tiziana Life Sciences Has Dosed First Patient...
Benzinga Newsdesk
Wednesday, December 13, 2023
Tesla Shares Hardly Damaged Despite Recall: Full Self-Driving Is Elon Musk's 'Holy Grail,' Analyst Says
Neil Dennis
Tuesday, December 12, 2023
Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
Neil Dennis
Thursday, November 30, 2023
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
Rachael Green
-
Sponsored
Tiziana Life Sciences Reveals Foralumab Dosin...
Benzinga Newsdesk
Wednesday, October 18, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tiziana Life Sciences Reports Allowance By FD...
Benzinga Newsdesk
Tuesday, October 17, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tiziana Life Sciences Announces New Clinical ...
Benzinga Newsdesk
Monday, October 16, 2023
Tiziana Life Sciences' Six-month Data Show Cl...
Benzinga Newsdesk
Friday, October 13, 2023
Tiziana Life Sciences Reveals Positive Qualit...
Benzinga Newsdesk
Thursday, October 12, 2023
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
Rachael Green
-
Sponsored
Wednesday, October 11, 2023
Tiziana Announces Presentation of Six-Month S...
Benzinga Newsdesk
Wednesday, October 04, 2023
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
Rachael Green
-
Sponsored
Wednesday, September 27, 2023
Tiziana Life Sciences Prepares To Advance Lead Intranasal Foralumab Program In First-Of-Its-Kind Phase 2a Clinical Trial for Non-Active SPMS Patients
Kenneth Adams
Tuesday, September 26, 2023
Tiziana Life Sciences Initiates Multi-Center ...
Bill Haddad
Tiziana Life Sciences Initiates Phase 2a Tria...
Benzinga Newsdesk
Friday, September 22, 2023
Poised For Growth? This Biotech Is Close To Beginning Key Phase 2a Study With Its Lead Candidate
Tiziana Life Sciences
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
